NCT03296592View on ClinicalTrials.gov

Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)

Active, not recruitingOBSERVATIONAL
Enrollment

71

Participants

Timeline

Start Date

January 29, 2018

Primary Completion Date

March 30, 2024

Study Completion Date

December 30, 2025

Conditions
Cervical Spondylotic Myelopathy
Interventions
DIAGNOSTIC_TEST

MRI with DBSI technology

The MRI will be done with diffusion basis spectrum imaging

Trial Locations (1)

63110

Washington University, St Louis

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Washington University School of Medicine

OTHER

NCT03296592 - Diffusion MRI in Cervical Spondylotic Myelopathy (CSM) | Biotech Hunter | Biotech Hunter